Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pires

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
BMC Microbiology|December 7, 2025
Effects of CwlM, a peptidoglycan synthesis regulator, on beta-lactam tolerance and host-pathogen interactionsCátia Silveiro, Diana Mortinho, Francisco Olivença, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within MacrophagesDavid Pires, Emília Valente, Marta Filipa Simões, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2024
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of <i>Mycobacterium tuberculosis</i>Francisco Olivença, David Pires, Cátia Silveiro, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 27, 2010
Probe-based 3-D nanolithography using self-amplified depolymerization polymersArmin W Knoll, David Pires, Olivier Coulembier, et al.
Reviews in Medical Virology|April 8, 2024
Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous systemMarta Calado, Rita Ferreira, David Pires, et al.
Viruses|May 27, 2023
Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T LymphocytesMarta Calado, David Pires, Carolina Conceição, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial <i>N</i>-Alkyl NitrobenzamidesJoão P Pais, Olha Antoniuk, David Pires, et al.
Scientific Reports|August 31, 2016
Role of Cathepsins in Mycobacterium tuberculosis Survival in Human MacrophagesDavid Pires, Joana Marques, João Palma Pombo, et al.
Plos One|February 27, 2016
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisDiana Machado, David Pires, João Perdigão, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide ScaffoldTiago Delgado, João P Pais, David Pires, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
BMC Microbiology|December 7, 2025
Effects of CwlM, a peptidoglycan synthesis regulator, on beta-lactam tolerance and host-pathogen interactionsCátia Silveiro, Diana Mortinho, Francisco Olivença, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within MacrophagesDavid Pires, Emília Valente, Marta Filipa Simões, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2024
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of <i>Mycobacterium tuberculosis</i>Francisco Olivença, David Pires, Cátia Silveiro, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 27, 2010
Probe-based 3-D nanolithography using self-amplified depolymerization polymersArmin W Knoll, David Pires, Olivier Coulembier, et al.
Reviews in Medical Virology|April 8, 2024
Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous systemMarta Calado, Rita Ferreira, David Pires, et al.
Viruses|May 27, 2023
Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T LymphocytesMarta Calado, David Pires, Carolina Conceição, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial <i>N</i>-Alkyl NitrobenzamidesJoão P Pais, Olha Antoniuk, David Pires, et al.
Scientific Reports|August 31, 2016
Role of Cathepsins in Mycobacterium tuberculosis Survival in Human MacrophagesDavid Pires, Joana Marques, João Palma Pombo, et al.
Plos One|February 27, 2016
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisDiana Machado, David Pires, João Perdigão, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide ScaffoldTiago Delgado, João P Pais, David Pires, et al.
Pageof 6